Mode
Text Size
Log in / Sign up

Type 1 Diabetes

Part of Diabetes

Subtypes of Type 1 Diabetes

Type 1 diabetes mellitus 6 Wolfram Syndrome 1

40 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Type 1 Diabetes

203 trials tracked for Type 1 Diabetes: 39 in phase 3 or 4 and 14 with published results. The most-cited published study has 178 citations.

203Trials tracked
39Phase 3 & 4
0Recruiting
14With published results
Phase distribution
Phase 4 14 Phase 3 25 Phase 2 29 Phase 1 9 Other / NA 126
  1. Phase 3 Metformin Therapy for Overweight Adolescents With Type 1 Diabetes Completed · 178 cited
  2. Phase 3 EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes Completed · 141 cited
  3. Phase 3 Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients Completed · 62 cited
  4. Phase 3 A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy Completed · 43 cited
  5. Phase 4 52 Week Trial of Liraglutide in Type 1 Diabetes Completed · 36 cited
  6. Phase 4 Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus Completed · 11 cited
Show 44 more trials
  1. Phase 4 Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes Completed · 6 cited
  2. Phase 4 Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes Completed · 6 cited
  3. Phase 3 Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy Completed · 6 cited
  4. Phase 4 Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings Completed · 4 cited
  5. Phase 3 Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) Completed · 4 cited
  6. Phase 3 A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus Completed · 2 cited
  7. Phase 4 A Study to Evaluate Pneumococcal Polysaccharide Vaccine Effectiveness in Children With Type 1 Diabetes Completed · 1 cited
  8. Phase 4 A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus Completed · 1 cited
  9. Phase 4 Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia Completed
  10. Phase 4 Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes Completed
  11. Phase 4 New Onset Type 1 Diabetes: Role of Exenatide Completed
  12. Phase 4 Insulin Pump to Multiple Daily Injection Transition Clinical Trial Completed
  13. Phase 4 Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes Completed
  14. Phase 4 Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose Completed
  15. Phase 4 Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness Completed
  16. Phase 3 Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon Completed
  17. Phase 3 A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes Completed
  18. Phase 3 Liraglutide In Overweight Patients With Type 1 Diabetes Completed
  19. Phase 3 Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes Completed
  20. Phase 3 Liraglutide in Type 1 Diabetes Completed
  21. Phase 3 Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes Completed
  22. Phase 3 Liraglutide in Adolescents With Type 1 Diabetes Completed
  23. Phase 3 A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D Completed
  24. Phase 3 Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration Completed
  25. Phase 3 Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon Completed
  26. Phase 3 Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature Completed
  27. Phase 3 STEP: Social Support To Empower Parents Completed
  28. Phase 3 Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes Completed
  29. Phase 3 Diabetic Retinopathy Candesartan Trials Completed
  30. Phase 3 New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy Completed
  31. Phase 3 DIabetic Retinopathy Candesartan Trials. Completed
  32. Phase 3 Liraglutide in the Treatment of Type 1 Diabetes Mellitus Completed
  33. Phase 3 Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes Completed
  34. Phase 2 Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes Completed
  35. Phase 2 CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Completed
  36. Phase 2 Transdermal Basal Insulin Patch Study in Type 1 Diabetes Completed
  37. Phase 2 Incretin Effect and Use After Clinical Islet Transplantation Completed
  38. Phase 2 Naltrexone and Hypoglycemia in Type 1 Diabetes Completed
  39. Phase 2 Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting Completed
  40. Phase 2 Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20) Completed
  41. Phase 2 DiaBetter Together for Young Adults With Type 1 Diabetes Completed
  42. Phase 2 Diabetes Prevention - Immune Tolerance Completed
  43. Phase 2 Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes Completed
  44. Phase 2 A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED) Completed

Showing the 50 most-cited and recently-updated of 203 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Diabetes

Related studies from across the Diabetes family.

A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Diabetes & Endocrinology Guideline
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes
Physical Medicine & Rehab Meta-analysis
Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care Outcomes Digital health tools show mixed results for managing chronic diseases
Digital tools show promise for heart failure monitoring but lack consistent evidence for improving medication adherence or general diabetes …
New data shows that while digital tools like apps can help heart failure patients monitor their health, they may not improve medication habi…
Pharmacist-led telepharmacy may improve medication adherence and reduce blood pressure in patients with NCDs
Cardiology Sys. Review
Pharmacist-led telepharmacy may improve medication adherence and reduce blood pressure in patients with NCDs Pharmacist Led Telepharmacy May Improve Medication Adherence For Chronic Illness
This systematic review analyzed 21 trials involving 5440 participants to evaluate pharmacist-led telepharmacy for managing non-communicable …
Remote pharmacist services through phone or video may help patients with high blood pressure and diabetes stick to their daily medication pl…
Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetes
Diabetes & Endocrinology Meta-analysis
Resveratrol supplementation significantly reduces LDL-C but lacks consistent impact on glycemic indices in type 2 diabetes Resveratrol fails to improve blood sugar in type 2 diabetes
This umbrella review and meta-analysis of 10 meta-analyses evaluated resveratrol for managing type 2 diabetes. While a significant reduction…
Resveratrol supplements did not lower blood sugar or improve cholesterol in type 2 diabetes, except for a small drop in LDL cholesterol.
Pancreatic cancer involves multilayered mechanisms from environment to immune escape
Diabetes & Endocrinology Sys. Review
Pancreatic cancer involves multilayered mechanisms from environment to immune escape Review reveals complex causes of pancreatic cancer
This narrative review synthesizes the multilayered mechanisms of pancreatic cancer, including environmental exposure, genetic susceptibility…
Pancreatic cancer arises from a mix of genetics, lifestyle, and inflammation, review finds.
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
Drug Pipeline Guideline
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
High prevalence of microvascular and macrovascular complications among adult Ugandans with diabetes
Diabetes & Endocrinology Meta-analysis
High prevalence of microvascular and macrovascular complications among adult Ugandans with diabetes High rates of diabetes complications found in adult Ugandans
This meta-analysis examined the prevalence of various diabetic complications, including neuropathy and retinopathy, in a large cohort of adu…
More than half of Ugandan adults with diabetes suffer from nerve damage, highlighting a critical need for earlier screening and better care.
SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes
Cardiology Meta-analysis
SGLT2 inhibitors associated with lower all-cause mortality in heart transplant recipients with type 2 diabetes SGLT2 inhibitors associated with lower mortality in heart transplant patients
This meta-analysis examined the impact of SGLT2 inhibitor use on outcomes for heart transplant recipients with type 2 diabetes. The authors …
New analysis suggests SGLT2 inhibitors may lower death rates for heart transplant recipients with type 2 diabetes without increasing UTI ris…
Immunometabolic dysregulation drives hyperalgesia and hypoesthesia in diabetic peripheral neuropathy
Neurology Sys. Review
Immunometabolic dysregulation drives hyperalgesia and hypoesthesia in diabetic peripheral neuropathy New research explores how inflammation drives nerve damage in diabetes
This narrative review explores the pathophysiology of diabetic peripheral neuropathy, focusing on how hyperglycemia, lipotoxicity, and intes…
Chronic high blood sugar causes more than just high glucose; it triggers a cycle of inflammation and immune stress that damages nerves.
Single-incision sleeve plus bypass shows short-term safety and metabolic improvement in 3 patients with obesity and T2DM
Orthopedics & Sports Medicine Sys. Review
Single-incision sleeve plus bypass shows short-term safety and metabolic improvement in 3 patients with obesity and T2DM SILSG-JJB Procedure Shows Promise for Weight Loss and Diabetes
This case report and review describes 3 female patients with severe obesity and type 2 diabetes who underwent single-incision laparoscopic s…
A new surgical approach may help people with severe obesity and Type 2 Diabetes achieve weight loss and better blood sugar levels.
Transcriptomic analysis identifies 337 high-confidence genes associated with Type 2 Diabetes in human pancreatic islets
Diabetes & Endocrinology Meta-analysis
Transcriptomic analysis identifies 337 high-confidence genes associated with Type 2 Diabetes in human pancreatic islets Meta-analysis reveals 337 genes linked to type 2 diabetes in islets
This meta-analysis of transcriptomic data from human pancreatic islets identified 337 high-confidence T2D-associated genes. The study also d…
A meta-analysis of human pancreatic islets identified 337 high-confidence genes tied to type 2 diabetes, and a 10-gene panel perfectly disti…
Chronic hyperglycemia causes multi-level nerve damage across the peripheral, autonomic, and central nervous systems
Diabetes & Endocrinology Sys. Review
Chronic hyperglycemia causes multi-level nerve damage across the peripheral, autonomic, and central nervous systems Understanding how high blood sugar damages the entire nervous system in diabetes
This narrative review synthesizes how chronic hyperglycemia impacts the entire neuroaxis in patients with diabetes. It details metabolic and…
High blood sugar can damage nerves throughout the whole body. This affects your senses, movement, and internal organs.

Questions about Type 1 Diabetes

Does the FDA approved drug Tzield delay the onset of Stage 3 Type 1 diabetes?

Yes, the FDA-approved drug Tzield (teplizumab) delays the onset of Stage 3 type 1 diabetes in people with Stage 2 disease.

Full answer →
Can semaglutide help reduce the total daily insulin dose for adults with Type 1 diabetes?

Yes, semaglutide can reduce total daily insulin dose in adults with type 1 diabetes and overweight or obesity, based on clinical trial and real-world data.

Full answer →

All Type 1 Diabetes Articles